Recombinant Pig FXYD3 is commercially available with the following specifications :
| Parameter | Details |
|---|---|
| Host System | E. coli, mammalian cells (HEK293), or wheat germ expression systems |
| Tag | His, GST, Myc, Fc, or fluorescent tags (e.g., TRITC) |
| Purity | ≥85% (SDS-PAGE verified) |
| Storage | -20°C in Tris/PBS buffer with 50% glycerol; avoid freeze-thaw cycles |
| Sequence Coverage | Amino acids 18–88 (UniProt: O97797), retaining functional domains |
FXYD3 stabilizes Na+/K+-ATPase by:
Competing with native FXYD proteins (e.g., FXYD1) for α1 subunit binding .
Protecting the β1 subunit from glutathionylation, a redox modification that inhibits ATPase activity .
Enhancing ion-pump turnover in oxidative stress conditions, such as during chemotherapy .
Overexpression of FXYD3 in pancreatic (BxPC-3) and breast (MCF-7) cancer cells confers resistance to doxorubicin by:
Maintaining ATPase activity, which mitigates drug-induced cytotoxicity .
Peptide derivatives (e.g., FXYD3-pep SKSK) displace native FXYD3, sensitizing tumors to chemotherapy .
Psoriasis: FXYD3 amplifies IL-17A signaling in keratinocytes, driving epidermal hyperplasia .
Glucose Metabolism: Overexpression in pancreatic β-cells impairs glucose-stimulated insulin secretion, linking it to diabetes pathophysiology .
Cancer Therapy: FXYD3-pep SKSK is used to counteract chemoresistance in FXYD3-overexpressing tumors .
Cardioprotection: Recombinant FXYD3 reverses angiotensin II-induced Na+/K+-ATPase inhibition in cardiomyocytes .
Psoriasis Models: Keratinocyte-specific FXYD3 knockout mice show reduced disease severity .
Recombinant Pig FXYD domain-containing ion transport regulator 3 (FXYD3) associates with and modulates the activity of the sodium/potassium-transporting ATPase (NKA), responsible for transporting Na+ out of and K+ into cells. FXYD3 reduces glutathionylation of the NKA β1 subunit (ATP1B1), thereby reversing glutathionylation-mediated inhibition of ATP1B1. Furthermore, FXYD3 expression in Xenopus oocytes induces a hyperpolarization-activated chloride current.
Recombinant pig FXYD3 is a member of the FXYD family, characterized by a 35-amino acid signature sequence domain that begins with the PFXYD motif. This domain contains 7 invariant and 6 highly conserved amino acids. The protein features a transmembrane domain and specific cysteine residues that are crucial for its function. When working with recombinant pig FXYD3, researchers should note that the protein has both intracellular and extracellular domains, with the PFXYD motif located near the membrane leaflet. The extracellular and cytoplasmic domains, except for the PFXYD motif and the cysteine-containing motif, are poorly conserved across the FXYD protein family .
Recombinant pig FXYD3 associates closely with Na+/K+-ATPase through specific binding interactions. The transmembrane domain and the extracellular PFXYD motif near the membrane leaflet form known bonds with α- and β Na+/K+-ATPase subunits. This interaction enables FXYD3 to regulate ion pump function by protecting the β1 subunit against glutathionylation, an oxidative modification that can destabilize the α1/β1 heterodimer and inhibit Na+/K+-ATPase activity. The specific cysteine residue in FXYD3 is critical for this protective effect. When designing experiments to study this interaction, researchers should consider co-immunoprecipitation assays to verify the association between pig FXYD3 and Na+/K+-ATPase subunits .
Pig FXYD3 functions primarily as a regulator of ion transport through its interaction with Na+/K+-ATPase. It exhibits several biochemical functions including ATPase binding, chloride channel activity, and sodium channel regulator activity. Some of these functions may be performed independently, while others require cooperation with other proteins. FXYD3 plays a critical role in protecting against oxidative stress-induced β1 subunit glutathionylation and Na+/K+-ATPase inhibition. Additionally, it may contribute to tumor progression when overexpressed in certain cancer cells. Researchers investigating pig FXYD3 should design experiments that can differentiate between its direct effects on ion channels and its modulatory effects through Na+/K+-ATPase regulation .
The pig FXYD3 gene undergoes alternative splicing, resulting in multiple transcript variants encoding distinct isoforms. When studying recombinant pig FXYD3, researchers should be aware of these splice variants (such as FXYD3a and FXYD3b identified in human studies) and their potential functional differences. To investigate this question methodologically, researchers should employ RT-PCR to quantify different splice variant expression levels in porcine tissues. Further, functional assays comparing the effects of different splice variants on Na+/K+-ATPase activity and response to oxidative stress should be conducted. Protein-protein interaction studies can also reveal whether different splice variants associate with distinct protein partners, potentially explaining functional divergence .
Studies have shown that brief exposure (approximately 15 minutes) of myocytes to recombinant FXYD3 can displace native FXYD1 protein. This displacement phenomenon offers a valuable experimental approach for manipulating FXYD protein function in cellular systems. To investigate this mechanism, researchers should design time-course experiments examining the kinetics of displacement using fluorescently tagged recombinant pig FXYD3. Co-immunoprecipitation assays before and after exposure to recombinant protein can quantify the displacement of native FXYD proteins from the Na+/K+-ATPase complex. Additionally, assessing changes in membrane localization using confocal microscopy can provide insights into the competitive binding dynamics between native and recombinant FXYD proteins .
The specific cysteine residue in FXYD3, bracketed by basic amino acids and conserved across most FXYD family members, is critical for protecting the Na+/K+-ATPase β1 subunit against glutathionylation. To study this mechanism in pig FXYD3, researchers should employ site-directed mutagenesis to generate cysteine-to-serine mutants (similar to the FXYD3-pep SKSK described in human studies). Glutathionylation assays using oxidized glutathione (GSSG) or glutathione (GSH)/hydrogen peroxide can then assess susceptibility to glutathionylation. Functional studies measuring Na+/K+-ATPase activity under oxidative stress conditions in the presence of wild-type versus mutant pig FXYD3 would further elucidate the protective mechanism. This approach provides a methodological framework for understanding structure-function relationships in pig FXYD3 .
When expressing recombinant pig FXYD3, researchers should consider multiple expression systems including E. coli, mammalian cells (e.g., HEK293), and in vitro cell-free systems. Each system offers distinct advantages for different experimental purposes. For bacterial expression, optimization of codon usage for pig FXYD3 is essential for efficient expression. When using mammalian expression systems, researchers should consider adding appropriate tags (His, GST, DDK, Myc, Avi, Fc, or SUMO) to facilitate purification while minimizing interference with protein function. For membrane protein expression, temperature, induction conditions, and detergent selection for solubilization are critical parameters to optimize. The success of expression should be verified by Western blot analysis using antibodies specific to pig FXYD3 or to the fusion tag .
To effectively use siRNA for pig FXYD3 knockdown, researchers should design siRNA sequences targeting conserved regions of the pig FXYD3 mRNA. Based on human FXYD3 knockdown protocols, transfection conditions should be optimized for the specific cell type being studied. Typically, a pool of three to five target-specific 19-25 nt siRNAs is more effective than a single sequence. The knockdown efficiency should be quantified by both RT-PCR (for mRNA levels) and Western blotting (for protein abundance). Researchers should establish a time course of knockdown efficiency, as the optimal time point for functional studies may vary depending on protein turnover rate. Including appropriate non-silencing control siRNAs is essential for distinguishing specific effects from general responses to transfection procedures .
To study the interaction between pig FXYD3 and Na+/K+-ATPase, several complementary approaches should be employed. Co-immunoprecipitation using antibodies against either pig FXYD3 or Na+/K+-ATPase subunits can confirm physical association in cellular contexts. Proximity ligation assays can visualize interactions in situ. For detailed structural information, crosslinking studies followed by mass spectrometry analysis can identify specific interaction sites. Functional assays measuring Na+/K+-ATPase activity in the presence of wild-type or mutant pig FXYD3 can establish the physiological relevance of the interaction. Additionally, researchers can use peptide derivatives of pig FXYD3 (similar to the FXYD3-pep CKCK and FXYD3-pep SKSK approaches described for human FXYD3) to competitively disrupt endogenous interactions and assess functional consequences .
Pig FXYD3 is involved in several pathways including ion channel transport, ion transport by P-type ATPases, and transmembrane transport of small molecules. To experimentally validate these pathway interactions, researchers should first conduct pathway enrichment analysis using bioinformatics tools based on pig FXYD3 interactome data. Subsequently, validation experiments should include phosphoproteomic analysis to identify changes in pathway activation states following FXYD3 manipulation. Pharmacological inhibitors of key pathway components can be used to determine dependency relationships. For instance, if studying pig FXYD3's role in ion transport pathways, researchers should measure ion flux in the presence of specific channel blockers with and without FXYD3 expression. Reporter assays for pathway-specific transcription factors can also provide functional readouts of pathway activity influenced by pig FXYD3 .
To comprehensively map pig FXYD3 protein-protein interaction networks, researchers should employ a multi-method approach. Initial screening can be performed using yeast two-hybrid systems with pig FXYD3 as bait. Positive interactions should then be validated using co-immunoprecipitation or pull-down assays in physiologically relevant cell types. For a global interaction map, proximity-dependent biotinylation (BioID or TurboID) with pig FXYD3 as the bait protein, followed by mass spectrometry, can identify both stable and transient interactors. Mammalian-membrane two-hybrid systems are particularly useful for identifying interactions involving membrane proteins like FXYD3. The interaction data should be analyzed for enriched biological processes and cellular compartments to provide insights into FXYD3 function. Known interactors from human studies, such as CREB3, NUDT3, NR4A1, MAPK6, CREB3L1, and FBXL12, should be specifically tested for conservation in the pig system .
While pig FXYD3's role in regulating Na+/K+-ATPase is well-established, its effects on other ion channels require further investigation. To study these broader impacts, researchers should employ patch-clamp electrophysiology to measure chloride conductance in cells with and without pig FXYD3 expression, given FXYD3's reported chloride channel activity. Fluorescent ion indicators can be used to monitor intracellular ion concentrations in real-time following FXYD3 manipulation. Additionally, researchers should investigate whether pig FXYD3 directly interacts with other ion channels using co-immunoprecipitation and proximity ligation assays. Comparative studies with other FXYD family members that have established ion channel regulatory functions can provide insights into unique versus shared functions of pig FXYD3 .
Fluorescently labeled pig FXYD3 derivatives provide powerful tools for studying protein localization and dynamics in live cells. Based on approaches used with human FXYD3, pig FXYD3 can be tagged with fluorophores like tetramethylrhodamine (TRITC) at the extracellular N-terminal. When designing such constructs, researchers should verify that tagging does not interfere with function through parallel activity assays. For live-cell imaging studies, confocal microscopy with appropriate excitation (e.g., 543 nm for TRITC) and emission (e.g., 572 nm for TRITC) wavelengths can track protein localization. Photobleaching techniques (FRAP, FLIP) can assess protein mobility within membranes. To study internalization and trafficking, pulse-chase experiments with differently colored labels can distinguish between protein populations. Co-localization studies with organelle markers can identify subcellular compartments where pig FXYD3 resides, which is particularly relevant given the perinuclear distribution observed for human FXYD3 derivatives .
Studying glutathionylation of pig FXYD3 requires careful experimental design to preserve and detect this reversible post-translational modification. Based on protocols used for human FXYD3 derivatives, researchers should induce glutathionylation using either oxidized glutathione (GSSG, 10 mM for 30 minutes) or reduced glutathione with hydrogen peroxide (10 mM GSH/100 mM H₂O₂ for 30 minutes). To block free thiols and prevent thiol-disulfide exchange reactions, N-Ethylmaleimide (NEM, 5 mM) should be added before cell lysis. Glutathionylation can be detected by immunoblotting with anti-glutathione antibodies after non-reducing SDS-PAGE. For site-specific analysis, mass spectrometry following enrichment of glutathionylated proteins should be employed. The functional impact of glutathionylation can be assessed by comparing wild-type pig FXYD3 with cysteine-to-serine mutants in Na+/K+-ATPase activity assays under oxidative stress conditions .
Designing peptide derivatives of pig FXYD3 for functional studies should follow the successful approaches used with human FXYD3. These derivatives should include the critical functional motifs while excluding poorly conserved regions. For studying the role of cysteine residues in protective effects against β1 subunit glutathionylation, researchers should create paired derivatives: one retaining the critical cysteine residues (similar to FXYD3-pep CKCK) and another with cysteine-to-serine mutations (similar to FXYD3-pep SKSK). The peptides should be synthesized with high purity (>95%) and verified by mass spectrometry. For cellular uptake studies, N-terminal fluorescent tags can be added. When designing competitive inhibitor peptides, researchers should focus on the transmembrane domain and the PFXYD motif that interact with Na+/K+-ATPase. Concentration-response experiments should establish optimal dosing, with 1 μM for 2 hours serving as a starting point based on human studies .
When faced with contradictory findings about pig FXYD3 function, researchers should employ a systematic approach to reconciliation. First, differences in experimental systems (cell types, expression levels, species variations) should be cataloged as potential sources of discrepancy. Meta-analysis techniques can then be applied to identify patterns across studies that might explain contradictions. For instance, if contradictory effects on ion transport are reported, researchers should examine whether differences correlate with expression levels of other FXYD family members that might compensate for or modify pig FXYD3 function. Direct comparative studies using standardized conditions across multiple cell types can resolve system-dependent effects. Additionally, researchers should consider post-translational modifications that might differ between experimental conditions, potentially altering protein function. When designing new experiments to resolve contradictions, including positive and negative controls from previous studies is essential for valid comparisons .
The statistical analysis of pig FXYD3 functional assay data should be tailored to the specific experimental design and data characteristics. For comparing activity between wild-type and mutant pig FXYD3 or between treatment conditions, appropriate statistical tests include t-tests (for two groups) or ANOVA followed by post-hoc tests (for multiple groups). When analyzing dose-response relationships, nonlinear regression models should be applied to estimate EC50/IC50 values and Hill coefficients. For time-course experiments, repeated measures ANOVA or mixed-effects models are most appropriate. Sample size calculations should be performed prior to experiments based on expected effect sizes from preliminary data. When analyzing complex datasets involving multiple variables (e.g., different mutations, treatments, and time points), multivariate analysis techniques such as principal component analysis can identify patterns and relationships. In all cases, researchers should report effect sizes along with p-values to indicate biological significance .
Differentiating between direct and indirect effects of pig FXYD3 on cellular phenotypes requires careful experimental design and analysis. Researchers should employ time-course studies to establish the temporal sequence of events following pig FXYD3 manipulation, as direct effects typically occur more rapidly than indirect ones. Dose-response relationships can also provide insights, as direct effects often show clearer concentration dependence. To establish causality, researchers should use rescue experiments in which specific downstream pathways are independently manipulated to determine if they bypass the need for pig FXYD3. When studying effects on cancer cell sensitivity to doxorubicin, for example, researchers should measure intermediate steps such as Na+/K+-ATPase activity, ATP levels, and redox status to establish the mechanistic chain linking FXYD3 to the ultimate phenotype. Comparing the effects of full-length pig FXYD3 with domain-specific peptide derivatives can also help map functions to specific protein regions, further clarifying direct versus indirect mechanisms .